NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) and Establishment Labs (NASDAQ:ESTA – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
Profitability
This table compares NeuroOne Medical Technologies and Establishment Labs’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NeuroOne Medical Technologies | -71.50% | -128.12% | -86.34% |
| Establishment Labs | -15.82% | -196.69% | -10.73% |
Analyst Recommendations
This is a breakdown of current recommendations for NeuroOne Medical Technologies and Establishment Labs, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NeuroOne Medical Technologies | 1 | 1 | 3 | 0 | 2.40 |
| Establishment Labs | 1 | 0 | 9 | 0 | 2.80 |
NeuroOne Medical Technologies currently has a consensus target price of $7.33, indicating a potential upside of 697.71%. Establishment Labs has a consensus target price of $98.56, indicating a potential upside of 54.48%. Given NeuroOne Medical Technologies’ higher possible upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Establishment Labs.
Volatility & Risk
NeuroOne Medical Technologies has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500.
Earnings & Valuation
This table compares NeuroOne Medical Technologies and Establishment Labs”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NeuroOne Medical Technologies | $9.47 million | 0.88 | -$3.61 million | ($0.95) | -0.97 |
| Establishment Labs | $211.08 million | 9.01 | -$51.06 million | ($1.31) | -48.70 |
NeuroOne Medical Technologies has higher earnings, but lower revenue than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than NeuroOne Medical Technologies, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Establishment Labs beats NeuroOne Medical Technologies on 8 of the 13 factors compared between the two stocks.
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
About Establishment Labs
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Receive News & Ratings for NeuroOne Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroOne Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
